Can a multistakeholder initiative improve transparency and accountability in the pharmaceutical sector? Evidence from the Medicines Transparency Alliance

• Ngā kaituhi matua: Taryn Vian, PhD (Author), Jillian Clare Kohler, PhD (Author), Deirdre Dimancesco, MBA (Author), Gilles Forte, PhD (Author)
• Hōputu: Pukapuka
• I whakaputaina: Elsevier, 2017-04-01T00:00:00Z.
• Ngā marau: article
• Urunga tuihono: Connect to this object online.

Background: Access to affordable quality essential medicines is crucial if universal health coverage and the Sustainable Development Goals are to be achieved. Multistakeholder initiatives might help to overcome barriers to access such as weak pharmaceutical sector governance and lack of transparency...